InvestorsObserver
×
News Home

Should You Buy Perrigo Company PLC (PRGO) Stock After it Has Gained 4.44% in a Week?

Thursday, November 05, 2020 10:10 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy Perrigo Company PLC (PRGO) Stock After it Has Gained 4.44% in a Week?

Overall market sentiment has been down on Perrigo Company PLC (PRGO) stock lately. PRGO receives a Bearish rating from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bearish
Perrigo Company PLC has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on PRGO!

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.

Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.

InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.

The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With PRGO Stock Today?

Perrigo Company PLC (PRGO) stock is trading at $44.42 as of 10:09 AM on Thursday, Nov 5, a gain of $3.15, or 7.63% from the previous closing price of $41.27. The stock has traded between $43.67 and $45.40 so far today. Volume today is 646,389 compared to average volume of 802,375.

To screen for more stocks like Perrigo Company PLC click here.

More About Perrigo Company PLC

Perrigo is the leading provider of over-the-counter generic drugs with over 100 global locations. The company was formed in 1887 as a packager of home remedies and has grown with the migration of prescriptions switching to OTC and later with strategic acquisitions. The company has a portfolio of more than 3,000 product formulations and 14,000 stock-keeping units. Most of its manufacturing and customer base reside in North America. With the most recent management change, the company announced a narrower focus on consumer wellness in conjunction with the divestiture of animal health, acquisition of Ranir Global Holdings, and plans to sell or spin off the prescription business.

Click Here to get the full Stock Score Report on Perrigo Company PLC (PRGO) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App